Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G/A MDxHealth SA Filed by: LYTTON LAURENCE W

August 17, 2026 4:07 PM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Percentage calculated based on 95,417,382 Ordinary Shares outstanding as of August 13, 2026, as reported in the Form 6-K filed by the Issuer on August 13, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: Percentage calculated based on 95,417,382 Ordinary Shares outstanding as of August 13, 2026, as reported in the Form 6-K filed by the Issuer on August 13, 2026.


SCHEDULE 13G



Laurence W. Lytton
Signature:/s/ Laurence W. Lytton
Name/Title:Reporting person
Date:08/17/2026
Lytton-Kambara Foundation
Signature:/s/ Laurence W. Lytton
Name/Title:President
Date:08/17/2026
Exhibit Information

EXHIBIT 99.1 - AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D OR 13G

ATTACHMENTS / EXHIBITS

JOINT FILING AGREEMENT

Categories

SEC Filings